Cargando…
Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration
The role of inflammation in the progression of neurodegenerative disease remains unclear. We have shown that systemic bacterial insults accelerate disease progression in animals and in patients with Alzheimer’s disease. Disease exacerbation is associated with exaggerated CNS inflammatory responses t...
Autores principales: | Field, Robert, Campion, Suzanne, Warren, Colleen, Murray, Carol, Cunningham, Colm |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334265/ https://www.ncbi.nlm.nih.gov/pubmed/20399848 http://dx.doi.org/10.1016/j.bbi.2010.04.004 |
Ejemplares similares
-
Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1β and IL-6
por: Murray, Carol L, et al.
Publicado: (2011) -
TLR3 Agonist Poly-IC Induces IL-33 and Promotes Myelin Repair
por: Natarajan, Chandramohan, et al.
Publicado: (2016) -
TLR3 agonists: RGC100, ARNAX, and poly-IC: a comparative review
por: Komal, Asma, et al.
Publicado: (2021) -
ICS-formoterol reliever versus ICS and short-acting β(2)-agonist reliever in asthma: a systematic review and meta-analysis
por: Hatter, Lee, et al.
Publicado: (2021) -
Direct Type I IFN but Not MDA5/TLR3 Activation of Dendritic Cells Is Required for Maturation and Metabolic Shift to Glycolysis after Poly IC Stimulation
por: Pantel, Austin, et al.
Publicado: (2014)